Increasing nonalcoholic fatty liver disease-related mortality rates in the United States from 1999 to 2022

Review Gastroenterology & Hepatology

Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population-based study and review of literature

Ashraf Almomani et al.

Summary: This study is the largest to assess the prevalence of lean nonalcoholic fatty liver disease (L-NAFLD) in the United States. The results show that L-NAFLD patients are at significantly higher risk for acute coronary syndromes, esophageal varices, and hepatocellular carcinoma.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement

Hannes Hagstrom et al.

Summary: By reaching consensus on ICD codes for EHR-based research, the generalizability and comparability of research results can be improved. The expert panel achieved high agreement and provided a detailed list of ICD codes for exposures and outcomes, along with suggestions for addressing common methodological issues.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM

Kelly Lee Hayward et al.

Summary: ICD-10-AM codes can accurately predict the presence of NAFLD/NASH and obesity, but may underestimate their prevalence in some cases. The detection accuracy for diabetes is high, with almost perfect concordance between the codes and documentation in medical records.

BMJ OPEN GASTROENTEROLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology